Nomia Highlights Need for Better Medical Device Supplier Oversight

Oliver Norman, chief revenue officer at Nomia, emphasizes the importance of clearer oversight for smaller suppliers in the medical device industry. These suppliers, often categorized as 'tail spend,' may involve hundreds or thousands of vendors across various functions, affecting compliance and operational efficiency. Despite their low value, such suppliers can influence critical operations, yet many exist outside the formal procurement processes. Robust management of these suppliers is essential as medical device development becomes more complex, impacting compliance and quality for manufacturers, which matters for investors looking at medical device firms.